di-exo-3-aminobicyclo[2.2.1]heptane-2-carboxylic acid | 88330-32-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: di-exo-3-aminobicyclo[2.2.1]heptane-2-carboxylic acid
• 英文别名: (1R,2S,3R,4S)-3-azaniumylbicyclo[2.2.1]heptane-2-carboxylate
• CAS: 88330-32-9
• 化学式: C₈H₁₃NO₂
• 分子量: 155.197
• InChiKey: JSYLGUSANAWARQ-JRTVQGFMSA-N

物化性质

• 熔点：
  275-278 °C
• 沸点：
  279°C (rough estimate)
• 密度：
  1.241
• 稳定性/保质期：
  遵照规定使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  -0.9
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  67.8
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 安全说明：
  S24/25
• 海关编码：
  2922499990

SDS

Name:	3-Exo-Aminobicyclo2.2.1Heptane-2-Exo-Carboxylic Acid 98% Material Safety Data Sheet
Synonym:	None known
CAS:	88330-32-9

Section 1 - Chemical Product MSDS Name:3-Exo-Aminobicyclo2.2.1Heptane-2-Exo-Carboxylic Acid 98% Material Safety Data Sheet
Synonym:None known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
88330-32-9	3-Exo-Aminobicyclo2.2.1Heptane-2-Exo	98	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 88330-32-9: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 275.00 - 278.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: soluble
Specific Gravity/Density:
Molecular Formula: C8H13NO2
Molecular Weight: 155.20

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 88330-32-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3-Exo-Aminobicyclo2.2.1Heptane-2-Exo-Carboxylic Acid - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 88330-32-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 88330-32-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 88330-32-9 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  di-exo-3-aminobicyclo[2.2.1]heptane-2-carboxylic acid 在 氢氧化钾 、 lithium aluminium tetrahydride 、 lead(II) nitrate 作用下， 以 四氢呋喃 为溶剂， 反应 20.25h， 生成 5,8-methano-4ar,5c,6,7,8c,8ac-hexahydro-4H-3,1-benzoxazin-2(1H)-thione
  参考文献：
  名称：

  立体化学研究。58。饱和杂环。39 †。与降冰片烷和降冰片烯融合的二氢-1,3-恶嗪，1,3-恶嗪-2-酮和1,3-恶嗪-2-硫酮的制备和空间结构

  摘要：

  3-内氨基双环[2.2.1]庚-5-烯-2-内羧酸（1），由内降冰片烯5-烯-2,3-二羧酸酐和类似的饱和顺式-外氨基酸（3）用氢化铝锂还原成氨基醇2和4 ; 后者通过芳胺基醚环化成亚甲基桥连的四氢-（6a-c）和六氢-3,1-苯并恶嗪（7b-d）。的内（2）和外（4）用氯甲酸乙酯和甲醇钠将氨基醇转化为亚甲基桥连的四氢-3,1-苯并恶嗪-2-酮（9）和六氢-3,1-苯并恶嗪-2-酮（12）；用二硫化碳对醇进行处理，通过二硫代氨基甲酸酯得到相应的2-硫酮（11、13）。结构通过红外光谱和核磁共振谱证实。

  DOI：

  10.1002/jhet.5570200509
• 作为产物：
  描述：

  4-氧代-3-AZA-三环[4.2.1.0(2.5)]壬烷 生成 di-exo-3-aminobicyclo[2.2.1]heptane-2-carboxylic acid
  参考文献：
  名称：

  BERNATH, GABOR;STAJER, GEZA;SZABO, E. ANGELA;SZOKE-MOLNAR, SZOLT;SOHAR, P+, MAGY KEM. FOLYOIRAT, 94,(1988) N1, C. 485-491

  摘要：

  DOI：

文献信息

• An alkaloid-mediated desymmetrization of meso-anhydrides via a nucleophilic ring opening with benzyl alcohol and its application in the synthesis of highly enantiomerically enriched β-amino acids
  作者：Carsten Bolm、Ingo Schiffers、Iuliana Atodiresei、Christian P.R. Hackenberger

  DOI：10.1016/s0957-4166(03)00579-2

  日期：2003.11

  permits the isolation of the products in analytically pure form and the recovery of the alkaloids almost quantitatively. These hemiesters can be converted to N-protected β-amino esters by means of Curtius degradation of the corresponding acyl azides. Subsequent cleavage of both protecting groups by a single reaction step leads to the free β-amino acids in excellent yields. The efficiency of this procedure

  描述了在苄醇存在下金鸡纳生物碱介导的前手性环酐的打开，导致旋光性半酯。通过使用奎宁或奎尼丁作为导向添加剂，将结构多样的酸酐转化为相应的苄基单酯，其中对映异构体的ee最高可达99％。一个简单的水后处理方案可以分离出分析纯形式的产物，并几乎定量地回收生物碱。这些半个学期可以转换为N-通过相应的酰基叠氮化物的库尔蒂斯降解来保护-β-氨基酯。随后通过单个反应步骤裂解两个保护基团以优异的产率得到游离的β-氨基酸。通过短时不对称合成杀真菌剂顺-喷他汀来证明该方法的效率，所述顺式-喷他霉素递送氨基酸的对映体过量> 99.7％。
• PEPTIDES AND PEPTIDOMIMETIC COMPOUNDS, THE MANUFACTURING THEREOF AS WELL AS THEIR USE FOR PREPARING A THERAPEUTICALLY AND/OR PREVENTIVELY ACTIVE PHARMACEUTICAL COMPOSITION
  申请人：PETZELBAUER Peter

  公开号：US20100081787A1

  公开（公告）日：2010-04-01

  Peptides, peptidomimetics and derivatives thereof of the general formula I: H 2 N-GHRPX 1 - β -X 4 X 5 X 6 X 7 X 8 X 9 X 10 -X 11 (I), in which X 1 -X 10 denote one of the 20 genetically coded amino acids, wherein X 8 , X 9 and X 10 may also denote a single chemical bond; X 11 denotes OR 1 in which R 1 equals hydrogen or (C 1 -C 10 ) alkyl NR 2 R 3 with R 2 and R 3 are equal or different and denote hydrogen, (C 1 -C 10 ) alkyl, or a residue —W-PEG 5-60K , in which the PEG residue is attached via a suitable spacer W to the N-atom, or a residue NH—Y-Z-PEG 5-60K , in which Y denotes a chemical bond or a genetically coded amino acids from the group S, C, K or R and Z denotes a spacer, via which a polyethylene glycol (PEG)-residue can be attached, and their physiologically acceptable salts, and β denotes an amino acid, or a peptidomimetic element, which induces a bend or turn in the peptide backbone.

  通用公式I：H2N-GHRPX1-β-X4X5X6X7X8X9X10-X11(I)中的肽、肽类似物和衍生物，其中X1-X10表示20种遗传编码的氨基酸之一，其中X8、X9和X10也可以表示单一化学键；X11表示OR1，其中R1等于氢或(C1-C10)烷基NR2R3，其中R2和R3相同或不同，表示氢、(C1-C10)烷基，或者残基—W-PEG5-60K，其中PEG残基通过适当的间隔物W连接到N-原子，或者残基NH—Y-Z-PEG5-60K，其中Y表示化学键或来自S、C、K或R组的遗传编码氨基酸，Z表示间隔物，通过该间隔物可以连接聚乙二醇（PEG）残基，并且它们的生理上可接受的盐，β表示氨基酸或诱导肽骨架中弯曲或转弯的肽类或肽类似元素。
• β、γ-氨基酸N-羧基硫代羰基环内酸酐单体的合成、聚合反应、聚合物制备及其应用
  申请人：华东理工大学

  公开号：CN112778236A

  公开（公告）日：2021-05-11

  本发明涉及一种β、γ‑氨基酸N‑羧基硫代羰基环内酸酐单体的合成、聚合反应、聚合物制备及其应用。β‑及γ‑氨基酸N‑羧基硫代羰基环内酸酐(β‑NTA，γ‑NTA)单体、其衍生聚合物及其制备方法和应用。本发明改善了传统的β‑及γ‑氨基酸聚合物的制备条件，对水分不敏感，可敞口聚合，实现了α‑氨基酸、β‑氨基酸和γ‑氨基酸共混或嵌段聚合物的合成，制备得到的氨基酸聚合物可于抗菌、抗肿瘤、组织工程、药物和基因递送、自组装材料等方面。
• Sterochemical Studies 107 Saturated heterocycles 111
  作者：Gábor Bernáth、Géza Stájer、Angela E. Szabó、Zsolt Szóke-Molnár、Pál Sohár、Gyula Argay、Alajos Kálmán

  DOI：10.1016/s0040-4020(01)81504-0

  日期：1987.1

  saturated methylene-bridged quinazoline-2,4-diones (7a-b) prepared from norbornane-diexo-β-amino acid (1) with isocyanates and PPA. When heated with PPA, compounds 9 can be isomerized to 7. For preparation of the unsaturated compounds 8, the amino acid 2 was converted into the acid amides (13) and cyclized with I,1'-carbonyl-diimidazole to tricyclic quinazoline-2,4-dione (8a-e), which decompose when

  由双异冰片降冰片烷和降冰片烯-氮杂环丁烷酮5和6与异氰酸芳基酯制备N-芳基氨基甲酰基取代的β-内酰胺（9和10）。与由降冰片烷-二exo-β-氨基酸（1）制得的饱和亚甲基桥连喹唑啉-2,4-二酮（7a-b）相比，该化合物的结构通过IR，NMR光谱和X射线分析得以阐明。与异氰酸酯和PPA。与PPA一起加热时，化合物9可以异构化为7。为制备不饱和化合物8，氨基酸2被转化为酰胺（13），并与I，1'-羰基-二咪唑环合成三环喹唑啉-2 ，4-二酮（8a-e），其在加热时分解，分解出环戊二烯以产生3-取代的尿嘧啶（14）。
• Reactions of Levulinic Acid with Norbornane/ene Amino Acids and Diamines
  作者：Géza Stájer、Angela E. Szabó、Antal Csámpai、Pál Sohár

  DOI：10.1002/ejoc.200300604

  日期：2004.3

  Whereas the cyclizations of di-endo-3-aminobicyclo[2.2.1]heptane-2-carboxylic acid (2) and di-endo-3-aminobicyclo[2.2.1]hept-5-ene-2-carboxylic acid (3) with 4-oxopentanoic acid (1) yield methanodioxopyrrolo[1,2-a][3,1]benzoxazines 6 and 7, the di-exo analogues give either the pyrrolo[1,2-a]pyridine 8 as sole product (in the case of 4), or 10 together with the methyl-substituted derivative 9 (in the

  而二-内-3-氨基双环[2.2.1]庚烷-2-羧酸(2)和二-内-3-氨基双环[2.2.1]庚-5-烯-2-羧酸(3 ) 与 4-氧代戊酸 (1) 产生甲二氧代吡咯并 [1,2-a][3,1] 苯并恶嗪 6 和 7，双外类似物得到吡咯并[1,2-a]吡啶 8 作为唯一产物（在4)的情况下，或10连同甲基取代衍生物9(在5的情况下)。化合物 1 与 di-exo-3-aminobicyclo[2.2.1]heptane-2-methanamine (11) 和 di-exo-3-aminobicyclo[2.2.1]hept-5-ene-2-methanamine (12) 反应生成分别得到亚甲基桥连的吡咯并[2,1-b]喹唑啉酮13和14；还分离了含有二吡咯并二氮杂15部分的五环产物。结构和立体化学通过 IR 和 NMR 光谱阐明，包括 COSY、DIFFNOE、DEPT、